Autorisation d’accès précoce refusée à la spécialité ZURZUVAE (zuranolone) dans l'indication « traitement de la dépression sévère du post-partum (DPP) suivant l’accouchement chez les adultes. »
See also
HAS opinions and decisions
23/06/2025
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
tfFYdZ8Ds76MS7uU
